S. Seber

810 total citations
56 papers, 516 citations indexed

About

S. Seber is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, S. Seber has authored 56 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 12 papers in Molecular Biology. Recurrent topics in S. Seber's work include Neuroendocrine Tumor Research Advances (7 papers), Lung Cancer Research Studies (5 papers) and HER2/EGFR in Cancer Research (4 papers). S. Seber is often cited by papers focused on Neuroendocrine Tumor Research Advances (7 papers), Lung Cancer Research Studies (5 papers) and HER2/EGFR in Cancer Research (4 papers). S. Seber collaborates with scholars based in Türkiye, United Kingdom and United States. S. Seber's co-authors include Taner Korkmaz, Yüksel Altuntaş, Sema Uçak, Okcan Basat, Gül Başaran, Özlem Harmankaya, Mürvet Yılmaz, Nazım Serdar Turhal, Mahmut Gümüş and Dilek Yavuzer and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Life Sciences.

In The Last Decade

S. Seber

51 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Seber Türkiye 13 142 130 97 94 84 56 516
Martin F. Reiner Switzerland 17 123 0.9× 152 1.2× 84 0.9× 128 1.4× 100 1.2× 47 697
Zahit Bolaman Türkiye 15 142 1.0× 123 0.9× 68 0.7× 102 1.1× 176 2.1× 63 803
Seung Jun Kim South Korea 10 145 1.0× 141 1.1× 98 1.0× 34 0.4× 64 0.8× 20 576
Gadi Shlomai Israel 13 112 0.8× 184 1.4× 77 0.8× 129 1.4× 112 1.3× 45 555
Buket Kın Tekçe Türkiye 14 163 1.1× 70 0.5× 171 1.8× 68 0.7× 70 0.8× 24 560
Fabiana Busti Italy 21 65 0.5× 170 1.3× 107 1.1× 89 0.9× 67 0.8× 47 1.3k
Ahmad Hamwi Austria 13 124 0.9× 117 0.9× 48 0.5× 115 1.2× 175 2.1× 22 573
Süleyman Hilmi İpekçi Türkiye 15 78 0.5× 97 0.7× 88 0.9× 63 0.7× 83 1.0× 45 487
Patricia Sorroche Argentina 16 46 0.3× 101 0.8× 67 0.7× 53 0.6× 137 1.6× 58 626

Countries citing papers authored by S. Seber

Since Specialization
Citations

This map shows the geographic impact of S. Seber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Seber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Seber more than expected).

Fields of papers citing papers by S. Seber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Seber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Seber. The network helps show where S. Seber may publish in the future.

Co-authorship network of co-authors of S. Seber

This figure shows the co-authorship network connecting the top 25 collaborators of S. Seber. A scholar is included among the top collaborators of S. Seber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Seber. S. Seber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seber, S., et al.. (2024). Efficacy of Neoadjuvant Chemotherapy in Lobular and Rare Subtypes of Breast Cancer. Journal of College of Physicians And Surgeons Pakistan. 34(1). 37–41. 2 indexed citations
2.
Seber, S., et al.. (2023). A logarithmic model for hormone receptor-positive and breast cancer patients treated with neoadjuvant chemotherapy. Revista da Associação Médica Brasileira. 69(3). 434–439. 1 indexed citations
3.
4.
Seber, S., et al.. (2023). A New Mortality Prediction Model in Advanced Stage Cancer Patients Requiring Hospitalisation while Receiving Active Systemic Therapy. Journal of College of Physicians And Surgeons Pakistan. 33(5). 548–553.
5.
Seber, S., et al.. (2022). Investigation of Serum Folate-Receptor-1 Levels in Patients with Non-Small Cell Lung Cancer. Konuralp Tıp Dergisi. 14(3). 526–532. 1 indexed citations
6.
Seber, S., et al.. (2022). Comprehensive Analysis of Prognostic Factors in Advanced Gastric Cancer Patients Treated with Chemotherapy. Journal of College of Physicians And Surgeons Pakistan. 32(11). 1420–1424. 4 indexed citations
7.
8.
9.
Seber, S., et al.. (2021). Mindfulness Among Medical Oncology Doctors and Its Relation With Burnout: Turkish Oncology Group (TOG) Study. JCO Oncology Practice. 17(7). e917–e924. 2 indexed citations
10.
Seber, S., et al.. (2016). Recurrent squamous cell carcinoma of the skin treated successfully with single agent cetuximab therapy. OncoTargets and Therapy. 9. 945–945. 4 indexed citations
11.
Seber, S., et al.. (2016). Cancer Stem Cells : Secret of Failure. SHILAP Revista de lepidopterología.
12.
Seber, S., et al.. (2016). Serum Tumor Marker Levels in Rheumatoid Arthritis. Acta Oncologica Turcica. 49(3). 237–242. 1 indexed citations
13.
Çabuk, Devrim, Gül Başaran, Faysal Dane, et al.. (2014). Clinical Outcome of Turkish Metastatic Breast Cancer Patients with Currently Available Treatment Modalities - Single Center Experience. Asian Pacific Journal of Cancer Prevention. 15(1). 117–122. 10 indexed citations
14.
Korkmaz, Taner, S. Seber, Gül Başaran, et al.. (2012). Serum thymidine kinase 1 levels correlates with FDG uptake and prognosis in patients with non small cell lung cancer. Biomarkers. 18(1). 88–94. 11 indexed citations
15.
Korkmaz, Taner, S. Seber, & Serdar Turhal. (2011). Primary melanoma of the gallbladder.. PubMed. 15(4). 802–802. 1 indexed citations
16.
Korkmaz, Taner, et al.. (2011). Prognostic significance of serum thymidine kinase activity (TK1) level in patients with metastatic non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 29(15_suppl). e18010–e18010.
17.
Başaran, Gül, Devrim Cabuk, Hale Başak Çağlar, et al.. (2010). Clinical outcome of breast cancer patients with N3a (≥10 positive lymph nodes) disease: has it changed over years?. Medical Oncology. 28(3). 726–732. 19 indexed citations
18.
Erkanlı, Korhan, et al.. (2007). Kalp Yetmezliğine Bağlı Akut Akciğer Ödemine Giren Hastada Ortaya Çıkan Diüretik Rezistansının Erken Ultrafiltrasyon İle Tedavisi. DergiPark (Istanbul University). 14(2). 111–113. 1 indexed citations
19.
Sargın, Haluk, Mehmet Sargın, Yüksel Altuntaş, et al.. (2003). Comparison of lunch and bedtime NPH insulin plus mealtime insulin Lispro therapy with premeal regular insulin plus bedtime NPH insulin therapy in type 2 diabetes. Diabetes Research and Clinical Practice. 62(2). 79–86. 10 indexed citations
20.
Harmankaya, Özlem, S. Seber, & Mürvet Yılmaz. (2003). Combination of Pentoxifylline with Angiotensin Converting Enzyme Inhibitors Produces an Additional Reduction in Microalbuminuria in Hypertensive Type 2 Diabetic Patients. Renal Failure. 25(3). 465–470. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin F. Reiner Breakdown of academic impact, for papers by Zahit Bolaman Breakdown of academic impact, for papers by Seung Jun Kim Breakdown of academic impact, for papers by Gadi Shlomai Breakdown of academic impact, for papers by Buket Kın Tekçe Breakdown of academic impact, for papers by Fabiana Busti Breakdown of academic impact, for papers by Ahmad Hamwi Breakdown of academic impact, for papers by Süleyman Hilmi İpekçi Breakdown of academic impact, for papers by Patricia Sorroche
Rankless by CCL
2026